December 9, 2022
UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.
July 23, 2021
Matthew Painschab, MD, and colleagues report that a five-drug combination chemotherapy provided curative benefit in people diagnosed with diffuse large B-cell lymphoma and is also a cost-effective option in Malawi.
October 21, 2019
The National Institutes of Health Fogarty International Center has awarded Matthew Painschab, MD, a five-year International Research Scientist Development Award to lead research into improving treatment for multicentric Castleman disease in Malawi. Working through the University of North Carolina Project-Malawi, a collaboration between UNC-Chapel Hill and the Malawi Ministry of Health, Painschab will lead a …
June 18, 2019
Three fellows in the UNC School of Medicine Division of Hematology/Oncology, Daniel Richardson, MD, Tim Voorhees, MD, and Matthew Painschab, MD, were selected to participate in the ASCO/AACR Methods in Clinical Cancer Research Workshop in Vail, Colorado, July 27-Aug. 2. The intensive workshop covers the essentials of effective clinical trial designs of therapeutic interventions in …
June 18, 2018
Matthew S. Painschab, MD, was one of seven researchers awarded with a Global Oncology Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) in the inaugural year of the program.
